| |
Article Title |
Author(s) |
Type |
Pages |
|
Transferrin Receptor 1: A Ferritin Receptor as Well?
September 2010 (Vol. 139 | No. 3 | Pages 1052-1053)
|
Daniel F. Wallace,
Cameron McDonald,
V. Nathan Subramaniam
|
Discussion
|
pages 1052-1053
|
|
Probiotics for Ulcerative Colitis … Are The Good Bugs Back?
September 2010 (Vol. 139 | No. 3 | Pages 1054-1056)
|
Shamita B. Shah
|
Discussion
|
pages 1054-1056
|
|
Reply
September 2010 (Vol. 139 | No. 3 | Page 1056)
|
Ajit Sood,
Vandana Midha,
Govind K. Makharia,
Vineet Ahuja,
Dinesh Singal,
Pooja Goswami,
Rakesh K. Tandon
et al.
|
Discussion
|
pages 1056-1056
|
|
Is Lack of “Education” a Mechanism Driving Loss of Tolerance in Crohn's Disease?
September 2010 (Vol. 139 | No. 3 | Pages 1056-1058)
|
Marisol Veny,
Azucena Salas,
Julian Panes
|
Discussion
|
pages 1056-1058
|
|
Reply
September 2010 (Vol. 139 | No. 3 | Pages 1058-1059)
|
Maria Rescigno,
Iliyan D. Iliev
|
Discussion
|
pages 1058-1059
|
|
Infliximab and Azathioprine for Crohn's Disease: A Super-Sonic Combination?
September 2010 (Vol. 139 | No. 3 | Pages 1059-1061)
|
Laurent Peyrin–Biroulet,
Silvio Danese
|
Discussion
|
pages 1059-1061
|
|
Treatment of Inflammatory Bowel Disease With Genetically Engineered Bacteria
August 2010 (Vol. 139 | No. 2 | Pages 685-687)
|
Alastair J.M. Watson,
Paul Collins
|
Discussion
|
pages 685-687
|
|
Antiplatelet Therapy During Gastrointestinal Bleeding: Risk or Benefit?
August 2010 (Vol. 139 | No. 2 | Pages 687-689)
|
Klaus Egger,
Hans Dieter Allescher
|
Discussion
|
pages 687-689
|
|
Differential Risk Depending on Parental Origin: A New Layer of Complexity for Genetic Susceptibility Variants
August 2010 (Vol. 139 | No. 2 | Pages 689-690)
|
Sergi Castellví–Bel,
Antoni Castells
|
Discussion
|
pages 689-690
|
|
To Bead or Not to Bead: Is Transarterial Chemoembolization With Doxorubicin-Eluting Beads a New Standard of Care in Hepatocellular Carcinoma?
August 2010 (Vol. 139 | No. 2 | Pages 690-692)
|
Joerg Trojan,
Stefan Zeuzem
|
Discussion
|
pages 690-692
|
|
Hippo Tumor Supressor Pathway: Novel Implications for the Treatment of Hepatocellular Carcinoma
August 2010 (Vol. 139 | No. 2 | Pages 692-694)
|
Anja Lachenmayer,
Yujin Hoshida,
Josep M. Llovet
|
Discussion
|
pages 692-694
|
|
Is It Time for Dosing Anti-TNF Antibody Therapy by Serum Level?
July 2010 (Vol. 139 | No. 1 | Pages 344-346)
|
Caroline Kerner,
Faten Aberra
|
Discussion
|
pages 344-346
|
|
Enteric Dysmotility: Validating the Wingate/Bangkok Classification
July 2010 (Vol. 139 | No. 1 | Pages 346-348)
|
Eamonn M.M. Quigley
|
Discussion
|
pages 346-348
|
|
Acupuncture for Irritable Bowel Syndrome: Sham or the Real Deal?
July 2010 (Vol. 139 | No. 1 | Pages 348-350)
|
Monthira Maneerattanaporn,
William D. Chey
|
Discussion
|
pages 348-350
|
|
Reply
July 2010 (Vol. 139 | No. 1 | Pages 350-351)
|
Anthony J. Lembo,
Ted J. Kaptchuk
|
Discussion
|
pages 350-351
|
|
Segmented Filamentous Bacteria Shape Intestinal Immunity
July 2010 (Vol. 139 | No. 1 | Pages 351-353)
|
Timothy L. Denning,
Shanthi V. Sitaraman
|
Discussion
|
pages 351-353
|
|
STAT3 Implicated in the Development of Colon Cancer: A Step Closer for Targeted Therapy?
July 2010 (Vol. 139 | No. 1 | Pages 353-355)
|
George K.K. Lau,
Dewei Ye
|
Discussion
|
pages 353-355
|
|
Genetic Variation in Interleukin-28B Predicts Hepatitis C Treatment-Induced Viral Clearance in Genotype 1 Patients: The Dawn of a New Era?
June 2010 (Vol. 138 | No. 7 | Pages 2546-2549)
|
Alessio Aghemo,
Massimo Colombo
|
Discussion
|
pages 2546-2549
|
|
A Novel Antibody for Autoimmune Pancreatitis: A Step Closer to a Single Diagnostic Test?
June 2010 (Vol. 138 | No. 7 | Pages 2549-2551)
|
Pari Shah,
Nuzhat A. Ahmad
|
Discussion
|
pages 2549-2551
|
|
Good Night, Sleep Tight … And Don't Let the Acid Bite!
June 2010 (Vol. 138 | No. 7 | Pages 2551-2553)
|
Lauren B. Gerson
|
Discussion
|
pages 2551-2553
|
